Aadi Bioscience (AADI) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free AADI Stock Alerts $1.90 +0.06 (+2.99%) (As of 01:39 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aadi Bioscience Short Interest DataCurrent Short Volume1,130,000 sharesPrevious Short Volume1,100,000 sharesChange Vs. Previous Month+2.73%Dollar Volume Sold Short$2.17 millionShort Interest Ratio / Days to Cover3.3Last Record DateApril 30, 2024Outstanding Shares24,550,000 sharesFloat Size17,380,000 sharesShort Percent of Float6.50%Today's Trading Volume34,529 sharesAverage Trading Volume332,871 sharesToday's Volume Vs. Average10% Short Selling Aadi Bioscience ? Sign up to receive the latest short interest report for Aadi Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAADI Short Interest Over TimeAADI Days to Cover Over TimeAADI Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. Aadi Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,130,000 shares $2.17 million +2.7%6.5%3.3 $1.92 4/15/20241,100,000 shares $2.09 million +16.6%6.3%3.2 $1.90 3/31/2024943,100 shares $2.21 million -16.5%5.4%2.4 $2.34 3/15/20241,130,000 shares $2.45 million +19.0%6.5%2.6 $2.17 2/29/2024949,300 shares $1.87 million -4.1%5.5%1.7 $1.97 2/15/2024990,300 shares $1.88 million -13.1%5.7%2.2 $1.90 Get the Latest News and Ratings for AADI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,140,000 shares $2.10 million +29.1%6.6%2.7 $1.84 1/15/2024883,200 shares $1.52 million +7.4%5.1%2.2 $1.72 12/31/2023822,200 shares $1.66 million +29.3%4.8%2.3 $2.02 12/15/2023635,900 shares $1.49 million -19.4%3.7%2.1 $2.34 11/30/2023789,000 shares $4.15 million +6.1%4.6%7.1 $5.26 11/15/2023743,700 shares $3.50 million -1.7%4.3%7 $4.71 10/31/2023756,600 shares $3.31 million -5.6%4.4%7 $4.38 10/15/2023801,300 shares $3.39 million +9.1%4.7%6.2 $4.23 9/30/2023734,700 shares $3.56 million +10.8%4.3%5.4 $4.84 9/15/2023662,900 shares $3.67 million +6.4%3.9%4.6 $5.54 8/31/2023623,300 shares $3.93 million -5.1%3.7%4.5 $6.30 8/15/2023656,500 shares $3.91 million -39.8%3.9%4.8 $5.95 7/31/20231,090,000 shares $5.81 million -4.4%6.4%8 $5.33 7/15/20231,140,000 shares $6.54 million +9.6%6.7%9 $5.74 6/30/20231,040,000 shares $7.11 million -14.1%6.1%8.6 $6.84 6/15/20231,210,000 shares $9.92 million +11.0%7.2%9.3 $8.20 5/31/20231,090,000 shares $8.72 million -15.5%6.5%8.5 $8.00 5/15/20231,290,000 shares $9.07 million +17.3%7.7%9 $7.03 4/30/20231,100,000 shares $8.54 million -2.7%6.8%7.3 $7.76 4/15/20231,130,000 shares $9.14 million -27.6%7.0%8 $8.09 3/31/20231,560,000 shares $11.29 million +7.6%9.7%11.5 $7.24 3/15/20231,450,000 shares $11.63 million +22.9%9.0%12.1 $8.02 2/28/20231,180,000 shares $12.71 million +6.3%7.3%11.3 $10.77 2/15/20231,110,000 shares $13.18 million +2.8%6.9%11.8 $11.87 1/31/20231,080,000 shares $13.63 million +3.9%6.4%12.9 $12.62 1/15/20231,040,000 shares $13.47 million -11.9%6.1%11.7 $12.95 12/30/20221,180,000 shares $15.14 million +12.4%7.0%13.6 $12.83 12/15/20221,050,000 shares $13.34 million No Change6.2%11.6 $12.70 11/30/20221,050,000 shares $14.05 million -0.9%6.2%9.6 $13.38 11/15/20221,060,000 shares $14.21 million +13.0%6.3%9.2 $13.41 10/31/2022937,900 shares $12.11 million +27.6%6.1%8 $12.92 10/15/2022735,100 shares $9.27 million -2.1%5.5%6.2 $12.61 9/30/2022750,600 shares $10.61 million +2.0%5.6%6 $14.13 9/15/2022735,800 shares $9.39 million +5.6%6.3%4.5 $12.76Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. AADI Short Interest - Frequently Asked Questions What is Aadi Bioscience's current short interest? Short interest is the volume of Aadi Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,130,000 shares of AADI short. 6.50% of Aadi Bioscience's shares are currently sold short. Learn More on Aadi Bioscience's current short interest. What is a good short interest ratio for Aadi Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AADI shares currently have a short interest ratio of 3.0. Learn More on Aadi Bioscience's short interest ratio. Which institutional investors are shorting Aadi Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aadi Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aadi Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.50% of Aadi Bioscience's floating shares are currently sold short. Is Aadi Bioscience's short interest increasing or decreasing? Aadi Bioscience saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,130,000 shares, an increase of 2.7% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aadi Bioscience's float size? Aadi Bioscience currently has issued a total of 24,550,000 shares. Some of Aadi Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aadi Bioscience currently has a public float of 17,380,000 shares. How does Aadi Bioscience's short interest compare to its competitors? 6.50% of Aadi Bioscience's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aadi Bioscience: Xilio Therapeutics, Inc. (5.24%), Ocuphire Pharma, Inc. (4.71%), Immuneering Co. (15.37%), HCW Biologics Inc. (0.05%), Unicycive Therapeutics, Inc. (2.13%), Gain Therapeutics, Inc. (1.02%), Lexaria Bioscience Corp. (2.29%), NextCure, Inc. (0.53%), Bolt Biotherapeutics, Inc. (8.80%), Eyenovia, Inc. (12.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aadi Bioscience stock? Short selling AADI is an investing strategy that aims to generate trading profit from Aadi Bioscience as its price is falling. AADI shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aadi Bioscience? A short squeeze for Aadi Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AADI, which in turn drives the price of the stock up even further. How often is Aadi Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AADI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Xilio Therapeutics Short Interest Data Ocuphire Pharma Short Interest Data Immuneering Short Interest Data HCW Biologics Short Interest Data Unicycive Therapeutics Short Interest Data Gain Therapeutics Short Interest Data Lexaria Bioscience Short Interest Data NextCure Short Interest Data Bolt Biotherapeutics Short Interest Data Eyenovia Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AADI) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold